⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 29, 2024Journal of the Neurological SciencesOpen Access

Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing

Alessia Manni Florian Oggiano C. Palazzo Valentina Panetta Concetta Domenica Gargano Vincenzo Mangialardi Tommaso Guerra Antonio Iaffaldano Francesca Caputo Pietro Iaffaldano Maddalena Ruggieri María Trojano Damiano Paolicelli

View Full Paper

Ask AI

Bookmark

Share

Abstract

Cladribine tablets (CLAD) for adult patients with highly active relapsing multiple sclerosis (RMS) have been available in Italy since 2018. We aimed to assess predictors of no-evidence-of-disease-activity-3 (NEDA-3) status after 24 months of the last dose of CLAD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Manni et al. (2024) studied this question.

synapsesocial.com/papers/68e67e05b6db643587607398 https://doi.org/10.1016/j.jns.2024.123070

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1From Clinical Trial Efficacy to Real-World Effectiveness and Safety: Two-Year Outcomes of Cladribine in Relapsing—Remitting Multiple SclerosisHuman Clinical Trial · 2026
2Effectiveness and Safety of Cladribine in Relapsing-Remitting Multiple Sclerosis in Clinical Practice: A 2-Year Multicenter Retrospective Open-Label StudyCohort Study · 2026
3Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy2024 · 1 citations
4Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina2024 · 8 citations
5Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (<scp>CladStop</scp>)2024 · 9 citations